Hannah Gilmore, MD
Director of Breast Pathology University Hospitals Cleveland Medical Center
Medical School
Case Western Reserve University School of Medicine, Cleveland, O
Residency
Anatomic and Clinical Pathology, Beth Israel Deaconess Medical Center, Boston, MA
Fellowship(s)
Breast Pathology, Beth Israel Deaconess Medical Center, Boston, MA
Area of Expertise
- Breast Pathology
- Anatomic Pathology
- Molecular Diagnostics
- Digital Pathology
- Biomarker Expression and Genomic Profiling
Years of Experience
Over 15 years
Certifications & Licensure
- Pathology – Anatomic & Clinical Pathology
Biography
Dr. Hannah Gilmore is a board-certified anatomic pathologist specializing in breast pathology at University Hospitals Cleveland Medical Center. She also serves as an Associate Professor of Pathology at Case Western Reserve University and is the Division Chief of Anatomic Pathology.
Dr. Gilmore’s research focuses on the pathogenesis of breast tumors and the identification of diagnostic, predictive, and prognostic markers. She has made significant contributions to the field through her publications and innovative changes in the practice of anatomic pathology, emphasizing subspecialization, multidisciplinary care, molecular diagnostics, and digital pathology.
As the College of American Pathologists representative to the National Accreditation Program for Breast Centers, Dr. Gilmore serves as Vice Chair of the Standards and Accreditation Committee. Her work integrates pathologic, radiologic, and genomic data to study cancer biology, with a particular interest in digital imaging.
Professional Memberships
- College of American Pathologists
- National Accreditation Program for Breast Centers
Selected Publications
- Toro P, et al. Computational pathology reveals unique spatial patterns of immune response in H&E images from COVID-19 autopsies: preliminary findings. JMI. 2021;8(S1).
- Xu J, et al. Convolutional neural network initialized active contour model with adaptive ellipse fitting for nuclear segmentation on breast histopathological images. JMI. 2019;6(1).
- Romo-Bucheli D, et al. Automated tubule nuclei quantification and correlation with oncotype DX risk categories in ER+ breast cancer whole slide images. Proc. SPIE. 2016;9791.
featured Articles
What is the Difference between Grading and Staging?
A cancer’s grade describes how abnormal the cancer cells and tissue look under a microscope when compared to healthy cells.
Understanding Breast Cancer Pathology
Dr. Gilmore’s expertise offers a unique perspective on the crucial role of pathology in breast cancer diagnosis and treatment.
Shining a Light on Male Breast Cancer: A New Resource Page
We’re excited to announce the launch of our new page dedicated to Male Breast Cancer.
Featured Interview
Expert Tips: Decoding Breast Cancer Pathology Reports
Testimonial
Latest News & Resources
News
Patient Resources
MEET OUR EXPERT MEDICAL TEAM
Explore the expertise of our medical advisors, who are dedicated to advancing breast cancer awareness, treatment, and support. Connect with our team and discover how their guidance contributes to the resources and insights available within our breast cancer support groups.
